1. REsect: Blinded assessment of resectability of previously unresectable colorectal cancer liver metastases following chemotherapy±Y90-RadioEmbolization. (2019) Authors: Garlipp, B.; Gibbs, P.; van Hazel, G.; Jeyarajah, R.; Martin, R.; Bruns, C.; Lang, H.; Manas, D.; Ettorre, G.M.; Pardo Sanchez, F.; Donckier, V.; Benckert, C.; van Gulik, T.; Goéré, D.; Schön, M.; Pratschke, J.; Bechstein, W.; Adeyemi, S.; Seidensticker, M. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. REsect: blinded assessment of resectability of previously unresectable colorectal cancer liver metastases following chemotherapy±Y90-RadioEmbolization. (2019) Authors: Garlipp, B.; Gibbs, P.; van Hazel, G.; Jeyarajah, R.; Martin, R.; Bruns, C.; Lang, H.; Manas, D.; Ettorre, G.M.; Pardo Sanchez, F.; Donckier, V.; Benckert, C.; van Gulik, T.; Goéré, D.; Schön, M.; Pratschke, J.; Bechstein, W.; Adeyemi, S.; Seidensticker, M. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗